FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Loxapine Capsules
Status: Currently in Shortage
»Date first posted: 11/25/2019
»Therapeutic Categories: Psychiatry

Expand all

Lannett Company, Inc. (New 11/25/2019)

Company Contact Information:
215-333-9000 ext. 4

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
5 mg, 100 count bottle (NDC 0527-1394-01) Out of stock, estimated availability in January/February 2020 Additional lots are scheduled for release in the January/February timeframe. Product will be made available as it is released. Other
5 mg, 1000 count bottle (NDC 0527-1394-10) Unavailable

Link to Discontinuance

Discontinuation of the manufacture of the drug
10 mg, 100 count bottle (NDC 0527-1395-01) Allocating inventory Additional lots are scheduled for release in the January/February timeframe. Other
10 mg, 1000 count bottle (NDC 0527-1395-10) Unavailable

Link to Discontinuance

Discontinuation of the manufacture of the drug
25 mg, 100 count bottle (NDC 0527-1396-01) Allocating Inventory Additional lots are scheduled for release in the January/February timeframe. Other
25 mg, 1000 count bottle (NDC 0527-1396-10) Unavailable

Link to Discontinuance

Discontinuation of the manufacture of the drug
50 mg, 100 count bottle (NDC 0527-1397-01) Allocating Inventory Additional lots are scheduled for release in the January/February timeframe. Other
50 mg, 1000 count bottle (NDC 0527-1397-10) Unavailable

Link to Discontinuance

Discontinuation of the manufacture of the drug

Mylan (New 11/25/2019)

Company Contact Information:
800-796-9526

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
5 mg, 100 count bottle (NDC 0378-7005-01) End Q1 2020 Other
10 mg, 100 count bottle (NDC 0378-7010-01) End Q1 2020 Other
25 mg, 100 count bottle (NDC 0378-7025-01) End Q1 2020 Other
50 mg, 100 count bottle (NDC 0378-7050-01) End Q1 2020 Other

Teva Pharmaceuticals (Reverified 12/04/2019)

Company Contact Information:
800-545-8800

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
5 mg, 100 count bottle (NDC 0591-0369-01) Product is available
10 mg, 100 count bottle (NDC 0591-0370-01) Availability and estimated duration of supply interruption is unknown Other
25 mg, 100 count bottle (NDC 0591-0371-01) Product is available
50 mg, 100 count bottle (NDC 0591-0372-01) Product is available

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English